First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.

For technical support, please send an email to: education@acmg.net  or call 301-718-9603.

Or click on the "Help"  icon on the left-hand side of your screen for more information.

Comprehensive Genomic Profiling in the Diagnosis of Central Nervous System Tumors 

Tuesday, March 28, 2023

11:00am-12:00pm ET

www.acmgeducation.net

Course Description:

In this course, Drs. Campregher, Paes, and Malheiros will present cases of Central Nervous System (CNS) tumors evaluated at Hospital Albert Einstein and discuss diagnostic challenges as well as the importance of integrating clinical, histological, and genomic information for accurate diagnosis and treatment.

Target Audience

All medical and healthcare professionals and researchers interested in understanding cancer genomic testing and somatic and germline variant interpretation methods. This series is presented as a collaboration between ClinGen Somatic, VICC, and ACMG consortia.

Agenda

Presentations followed by live Q&A. 

Learning Objectives

At the conclusion of this session, participants should be able to:

1. Classify specific CNS tumor types
2. Integrate clinical, histological, and molecular information for CNS tumors classification

Moderator:

Jason Saliba, PhD

Senior Scientist at Washington University School of Medicine in St. Louis

Presenters:

Paulo Vidal Campregher, MD, PhD

Associate Professor at Albert Einstein Graduate Program in Health Sciences

Hospital Israelita Albert Einstein, Sao Paulo, Brazil

Dr. Campregher is a hematologist and molecular pathologist with a focus on molecular diagnosis. He works at the clinical laboratory of Hospital Albert Einstein since 2011 developing NGS assays for diagnosis in oncology and hematology. He is an associate professor at Albert Einstein Graduate Program in Health Sciences and the coordinator of courses in Precision Medicine applied to oncology, hematology and pediatric oncology.

Suzana Maria Fleury Malheiros, MD, PhD

Neuro-oncologist - Hospital Israelita Albert Einstein

Hospital Israelita Albert Einstein - Sao Paulo, Brazil

Dr. Malheiros is a neurologist with a focus on neuro-oncology. She has been working at the Centro de Oncologia at Hospital Albert Einstein since 2008 as Neuro-oncology consultant. She also headed the Neuro-oncology Section of the Department of Neurology and Neurosurgery at Universidade Federal de São Paulo from 1992 to 2014.

Vitor Ribeiro Paes, MD

Pathologist – Hospital Israelita Albert Einstein

Hospital Israelita Albert Einstein - Sao Paulo, Brazil

Dr. Paes is a pathologist specialized in central nervous system and lung pathology. He is currently an attending physician at the Pathology Department of the University of Sao Paulo Medical School and also works at the Hospital Israelita Albert Einstein's Pathology Laboratory developing teaching and assistance activities.

Planning Committee:

Beth Pitel, MS, CG(ASCP)
Gordana Raca, MD, PhD, FACMG
Manuela Benary, PhD
Jason Saliba, PhD
Jane Radford, MHA, CHCP

Claudia Barnett  

CME Educational Credits:

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

Claiming your Educational Credits

Complete the activity and carefully complete the evaluation form. The deadline to claim educational credits is within 30 days from the date of the activity. Educational credit requests after this date will not be accepted.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

All of the relevant financial relationships listed for these individuals have been mitigated.